Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.061 AUD | 0.00% | 0.00% | +1.67% |
Feb. 25 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Jan. 19 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Sales 2022 | 446K 297K | Sales 2023 | 149K 99.41K | Capitalization | 13.88M 9.24M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.33M | Net income 2023 | -3M -2M | EV / Sales 2022 | 37.7 x |
Net cash position 2022 | 6.34M 4.22M | Net cash position 2023 | 2.99M 1.99M | EV / Sales 2023 | 72.9 x |
P/E ratio 2022 |
-6.84
x | P/E ratio 2023 |
-4.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.93% |
Current month | -6.15% | ||
1 month | -18.67% | ||
3 months | +24.49% | ||
6 months | +8.93% | ||
Current year | +1.67% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Grogan
CEO | Chief Executive Officer | - | 23-08-27 |
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sarah Driessens
LAW | General Counsel | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Andrew Guthrie
BRD | Director/Board Member | - | 21-04-25 |
Alex Ding
CHM | Chairman | - | 23-05-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.061 | 0.00% | 5 269 |
24-05-15 | 0.061 | 0.00% | 12,000 |
24-05-14 | 0.061 | +1.67% | 8,712 |
Delayed Quote Australian S.E., May 16, 2024 at 09:07 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.67% | 8.2M | |
+16.84% | 39.03B | |
-.--% | 11.3B | |
+1.76% | 8.01B | |
+2.60% | 6.55B | |
-2.15% | 6.21B | |
-2.74% | 5.85B | |
+38.21% | 5.48B | |
-15.39% | 5.24B | |
-12.68% | 4.59B |
- Stock Market
- Equities
- BGT Stock